212 related articles for article (PubMed ID: 8945573)
1. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis.
Li J; Scott P; Farrell JP
Infect Immun; 1996 Dec; 64(12):5248-54. PubMed ID: 8945573
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
3. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.
Nabors GS; Nolan T; Croop W; Li J; Farrell JP
Parasite Immunol; 1995 Nov; 17(11):569-79. PubMed ID: 8817603
[TBL] [Abstract][Full Text] [Related]
4. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production.
Li J; Hunter CA; Farrell JP
J Immunol; 1999 Jan; 162(2):974-9. PubMed ID: 9916722
[TBL] [Abstract][Full Text] [Related]
5. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.
Nabors GS; Farrell JP
Infect Immun; 1994 Dec; 62(12):5498-504. PubMed ID: 7960131
[TBL] [Abstract][Full Text] [Related]
6. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
[TBL] [Abstract][Full Text] [Related]
8. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
9. Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production.
Li J; Sutterwala S; Farrell JP
Infect Immun; 1997 Aug; 65(8):3225-30. PubMed ID: 9234779
[TBL] [Abstract][Full Text] [Related]
10. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
[TBL] [Abstract][Full Text] [Related]
11. An in vitro model for infection with Leishmania major that mimics the immune response in mice.
Soares MB; David JR; Titus RG
Infect Immun; 1997 Jul; 65(7):2837-45. PubMed ID: 9199457
[TBL] [Abstract][Full Text] [Related]
12. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
Chakir H; Campos-Neto A; Mojibian M; Webb JR
Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
Noben-Trauth N; Kropf P; Müller I
Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice.
Von Stebut E; Ehrchen JM; Belkaid Y; Kostka SL; Molle K; Knop J; Sunderkotter C; Udey MC
J Exp Med; 2003 Jul; 198(2):191-9. PubMed ID: 12860932
[TBL] [Abstract][Full Text] [Related]
15. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
16. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response.
Schopf LR; Bliss JL; Lavigne LM; Chung CL; Wolf SF; Sypek JP
Infect Immun; 1999 May; 67(5):2166-71. PubMed ID: 10225870
[TBL] [Abstract][Full Text] [Related]
18. Acute IL-4 Governs Pathogenic T Cell Responses during
Poudel B; Yorek MS; Mazgaeen L; Brown SA; Kanneganti TD; Gurung P
Immunohorizons; 2020 Sep; 4(9):546-560. PubMed ID: 32948646
[No Abstract] [Full Text] [Related]
19. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
[TBL] [Abstract][Full Text] [Related]
20. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response.
Swihart K; Fruth U; Messmer N; Hug K; Behin R; Huang S; Del Giudice G; Aguet M; Louis JA
J Exp Med; 1995 Mar; 181(3):961-71. PubMed ID: 7869054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
